Search Team

Search by Last Name
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Fish Litigation Blog

Welcome to the Fish & Richardson litigation blog, a community site where our intellectual property, commercial, and white collar litigators share information on nationwide litigation developments and trends. Join the conversation!

Fish Litigation Blog
Filter blogs by
Webinars

Fish Litigation Blog

The depth and breadth of Fish’s litigation practice is constantly expanding to fit the needs of our clients and the realities of the economic, business, and technological challenges they face. Our litigation blog reflects the full expanse of our litigation practice. Among other things, we discuss: developments in patent and trademark litigation, intricacies associated with ITC proceeding, Federal Circuit summaries and Supreme Court decisions, how courts are handling NPE litigation, various manifestations of the America Invents Act (AIA), commercial and business litigation matters, the Delaware Court of Chancery, and white collar defense and government investigation issues.

q&a 2016

Welcome to the conversation!

 


IP Litigation, Life Sciences
April 28, 2017
Law360: Justices Struggle With BPCIA Enigma
Authors: Jenny Shmuel, Ph.D., Tasha M. Francis, Ph.D.
IP Litigation
April 7, 2017
Minnesota Patent Litigation Wrap-Up - March
Author: Conrad Gosen
IP Litigation
April 7, 2017
Protective Agreements Before and During BPCIA Litigation: Prosecution and Regulatory Bars
Authors: ​Noorossadat Torabi, Ph.D., Jenny Shmuel, Ph.D., Tasha M. Francis, Ph.D.
IP Litigation
March 30, 2017
Fish Presents Inter Partes Review Master Course at The University of Iowa College of Law
Author: Phillip W. Goter
IP Litigation, Federal Circuit
March 24, 2017
Federal Circuit Opinion Astrazeneca v. Apotex Cites Patent Damages Treatise
Author: Christopher Marchese
IP Litigation, Life Sciences
March 15, 2017
Law 360: A Dive Into BPCIA Confidential Info Disclosure Requirements
Authors: Will Orlady, Tasha M. Francis, Ph.D.
IP Litigation, Life Sciences
March 14, 2017
First Biosimilar Monoclonal Antibody in Oncology Granted EU Approval: Implications for the U.S. Market
Authors: Jenny Shmuel, Ph.D., Ron Vogel, Tasha M. Francis, Ph.D.
IP Litigation
March 13, 2017
Dismissal Demonstrates Need for Clarity on BPCIA Disclosure Steps
Author: Jenny Shmuel, Ph.D.
IP Litigation
March 8, 2017
Minnesota Patent Litigation Wrap-Up – February 2017
Authors: Conrad Gosen, John C. Adkisson
IP Litigation, Life Sciences
March 3, 2017
REMICADE® Cell Powder Trial Postponed While Court Addresses Standing and BPCIA Remedies
Author: Jenny Shmuel, Ph.D.
IP Litigation, Life Sciences
March 3, 2017
Mixed Results When New Attribution Standard is Put to the Test with Life Science Divided-Actor Method Claims
Authors: Betsy Flanagan, Tasha M. Francis, Ph.D.
load more posts

Stay current with Fish Sign up for our Newsletter